(1) In patients over 65 with myocardial infarction, E/e' above 12 is an independent predictor of death during 1-year follow-up. (2) E/e' ratio in acute phase of myocardial infarction correlated significantly with N pro-BNP level and 6-minute walking distance after 1-year follow-up.
Background: Renin -angiotensin-system activity, a principal factor determining ventricular remodelling after myocardial infarction (MI), is dependant on local angiotensin II concentration and angiotensin AT 1 receptor (AT 1 R) density. The latter is regulated by systemic factors acting independently from angiotensin II concentration. Objective: To test the hypothesis that AT 1 R density at the onset of MI determines post-MI ventricular remodelling. Methods: In 48 patients with first acute MI who did not undergo reperfusion therapy, angiotensin AT 1 R density on blood platelets (reflecting cardiovascular AT 1 R density) was assessed 13 T 5 h after the onset of MI, using radioligand binding assay. Left ventricular end-systolic (LVESVI) and end-diastolic volume indices (LVEDVI) and ejection fraction (EF) were assessed by two-dimensional echocardiography as measures of ventricular remodelling. Results: Predischarge LVESVI and LVEDVI positively and EF negatively correlated with AT 1 R density. Patients with AT 1 R density below median had significantly lower LVESVI (33.2 T 2.4 mL/m 2 ), LVEDVI (70.0 T 2.8 mL/m 2 ) and higher EF (52.8 T 2.3%) than patients with AT 1 R density above median (LVESVI = 44.9 T 2.6, LVEDVI = 81.3 T 3.9 mL/m 2 and EF = 44.9 T 2.6%, all p < 0.01). In multivariate analysis, only AT 1 R density and infarct size were independent predictors of early post-MI ventricular dilation. Conclusions: High density of AT 1 R at the onset of MI is a predictor of early left ventricular remodelling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.